Form 8-K Karyopharm Therapeutics For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Karyopharm Therapeutics (KPTI) Tops Q3 EPS by 2c
November 9, 2015 9:22 AM ESTKaryopharm Therapeutics (NASDAQ: KPTI) reported Q3 EPS of ($0.85), $0.02 better than the analyst estimate of ($0.87).
For earnings history and earnings-related data on Karyopharm Therapeutics (KPTI) click here.
... More